OCRL and oculocerebrorenal syndrome: Disrupting the phosphatase activity of OCRL interferes with PI(4,5)P2 homeostasis, which is thought to contribute to the disease manifestations of Lowe syndrome (De Leo et al., 2016; Lowe, 2005; Vicinanza et al., 2011).